Accelerant is scaling a data-driven specialty-insurance exchange that connects managing general agents with risk-capital providers; as of June 30, 2026, the platform had 314 members and 97 risk-capital partners. The filing does not change that operating story—it advances the pending ownership transition around it.
The deal cleared its main market-check window without a competing bid. Accelerant’s 40-day go-shop period expired on September 22, 2026, and the company said it received no alternative acquisition proposals. 〔0〕 That is incremental confirmation rather than a surprise: the merger was already announced on August 13, and the go-shop was a scheduled process. It removes the possibility of a disclosed rival offer, but does not by itself change the agreed economics.
The announced take-private remains the operative path. Thoma Bravo affiliates are still set to acquire Accelerant in an all-cash transaction valued at more than $4 billion in enterprise value. The filing provides no new price, financing, operating forecast, or strategic terms, so there is no fresh earnings or business-performance signal to score against consensus.
Execution risk remains, but the timeline is unchanged. The company still expects closing in the first half of 2027, subject to shareholder approval and regulatory clearances. 〔1〕 If completed, Accelerant will leave the public markets and become privately held. 〔2〕
Bottom line: This is a procedural de-risking of the already announced acquisition, not a new valuation or operating development. The absence of rival bids leaves the Thoma Bravo transaction as the clear path, with shareholder and regulatory approvals still outstanding.
Read the original 8-K on SEC EDGAR ↗